nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—prostate cancer—Dexamethasone—psoriatic arthritis	0.331	0.5	CpDpCtD
Fentanyl—prostate cancer—Betamethasone—psoriatic arthritis	0.331	0.5	CpDpCtD
Fentanyl—ABCB1—Methylprednisolone—psoriatic arthritis	0.0268	0.123	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0207	0.0953	CbGbCtD
Fentanyl—CYP3A7—Dexamethasone—psoriatic arthritis	0.0207	0.0953	CbGbCtD
Fentanyl—ABCB1—Betamethasone—psoriatic arthritis	0.0174	0.08	CbGbCtD
Fentanyl—ABCB1—Prednisolone—psoriatic arthritis	0.0172	0.0789	CbGbCtD
Fentanyl—ABCB1—Prednisone—psoriatic arthritis	0.0162	0.0746	CbGbCtD
Fentanyl—CYP3A4—Methylprednisolone—psoriatic arthritis	0.016	0.0737	CbGbCtD
Fentanyl—CYP3A5—Dexamethasone—psoriatic arthritis	0.0156	0.0715	CbGbCtD
Fentanyl—CYP3A4—Triamcinolone—psoriatic arthritis	0.0122	0.0559	CbGbCtD
Fentanyl—CYP3A4—Betamethasone—psoriatic arthritis	0.0104	0.0479	CbGbCtD
Fentanyl—CYP3A4—Prednisolone—psoriatic arthritis	0.0103	0.0473	CbGbCtD
Fentanyl—ABCB1—Dexamethasone—psoriatic arthritis	0.0101	0.0465	CbGbCtD
Fentanyl—CYP3A4—Prednisone—psoriatic arthritis	0.00972	0.0447	CbGbCtD
Fentanyl—ABCB1—Methotrexate—psoriatic arthritis	0.00814	0.0374	CbGbCtD
Fentanyl—CYP3A4—Dexamethasone—psoriatic arthritis	0.00607	0.0279	CbGbCtD
Fentanyl—Quinapril—ACE—psoriatic arthritis	0.000791	0.535	CrCbGaD
Fentanyl—Benazepril—ACE—psoriatic arthritis	0.000688	0.465	CrCbGaD
Fentanyl—Shock—Methylprednisolone—psoriatic arthritis	7.17e-05	0.000603	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—psoriatic arthritis	7.15e-05	0.000601	CcSEcCtD
Fentanyl—Nervous system disorder—Methylprednisolone—psoriatic arthritis	7.15e-05	0.000601	CcSEcCtD
Fentanyl—Loss of consciousness—Dexamethasone—psoriatic arthritis	7.14e-05	0.0006	CcSEcCtD
Fentanyl—Loss of consciousness—Betamethasone—psoriatic arthritis	7.14e-05	0.0006	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—psoriatic arthritis	7.13e-05	0.0006	CcSEcCtD
Fentanyl—Paraesthesia—Prednisolone—psoriatic arthritis	7.13e-05	0.0006	CcSEcCtD
Fentanyl—Tachycardia—Triamcinolone—psoriatic arthritis	7.13e-05	0.000599	CcSEcCtD
Fentanyl—Mental disorder—Prednisone—psoriatic arthritis	7.12e-05	0.000598	CcSEcCtD
Fentanyl—Tachycardia—Methylprednisolone—psoriatic arthritis	7.11e-05	0.000598	CcSEcCtD
Fentanyl—Skin disorder—Methylprednisolone—psoriatic arthritis	7.08e-05	0.000595	CcSEcCtD
Fentanyl—Erythema—Prednisone—psoriatic arthritis	7.07e-05	0.000595	CcSEcCtD
Fentanyl—Malnutrition—Prednisone—psoriatic arthritis	7.07e-05	0.000595	CcSEcCtD
Fentanyl—Hyperhidrosis—Triamcinolone—psoriatic arthritis	7.06e-05	0.000594	CcSEcCtD
Fentanyl—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	7.04e-05	0.000592	CcSEcCtD
Fentanyl—Convulsion—Betamethasone—psoriatic arthritis	7.04e-05	0.000591	CcSEcCtD
Fentanyl—Convulsion—Dexamethasone—psoriatic arthritis	7.04e-05	0.000591	CcSEcCtD
Fentanyl—Hypertension—Dexamethasone—psoriatic arthritis	7.01e-05	0.000589	CcSEcCtD
Fentanyl—Hypertension—Betamethasone—psoriatic arthritis	7.01e-05	0.000589	CcSEcCtD
Fentanyl—Myalgia—Betamethasone—psoriatic arthritis	6.91e-05	0.000581	CcSEcCtD
Fentanyl—Myalgia—Dexamethasone—psoriatic arthritis	6.91e-05	0.000581	CcSEcCtD
Fentanyl—Anxiety—Dexamethasone—psoriatic arthritis	6.89e-05	0.000579	CcSEcCtD
Fentanyl—Anxiety—Betamethasone—psoriatic arthritis	6.89e-05	0.000579	CcSEcCtD
Fentanyl—Discomfort—Betamethasone—psoriatic arthritis	6.83e-05	0.000574	CcSEcCtD
Fentanyl—Discomfort—Dexamethasone—psoriatic arthritis	6.83e-05	0.000574	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—psoriatic arthritis	6.82e-05	0.000574	CcSEcCtD
Fentanyl—Hypotension—Methylprednisolone—psoriatic arthritis	6.81e-05	0.000572	CcSEcCtD
Fentanyl—Pain—Prednisolone—psoriatic arthritis	6.79e-05	0.000571	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—psoriatic arthritis	6.79e-05	0.000571	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—psoriatic arthritis	6.74e-05	0.000566	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—psoriatic arthritis	6.7e-05	0.000564	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—psoriatic arthritis	6.66e-05	0.00056	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—psoriatic arthritis	6.65e-05	0.000559	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	6.65e-05	0.000559	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	6.64e-05	0.000558	CcSEcCtD
Fentanyl—Oedema—Betamethasone—psoriatic arthritis	6.63e-05	0.000557	CcSEcCtD
Fentanyl—Anaphylactic shock—Dexamethasone—psoriatic arthritis	6.63e-05	0.000557	CcSEcCtD
Fentanyl—Oedema—Dexamethasone—psoriatic arthritis	6.63e-05	0.000557	CcSEcCtD
Fentanyl—Anaphylactic shock—Betamethasone—psoriatic arthritis	6.63e-05	0.000557	CcSEcCtD
Fentanyl—Insomnia—Triamcinolone—psoriatic arthritis	6.61e-05	0.000555	CcSEcCtD
Fentanyl—Insomnia—Methylprednisolone—psoriatic arthritis	6.59e-05	0.000554	CcSEcCtD
Fentanyl—Infection—Dexamethasone—psoriatic arthritis	6.58e-05	0.000554	CcSEcCtD
Fentanyl—Infection—Betamethasone—psoriatic arthritis	6.58e-05	0.000554	CcSEcCtD
Fentanyl—Ill-defined disorder—Prednisone—psoriatic arthritis	6.56e-05	0.000552	CcSEcCtD
Fentanyl—Paraesthesia—Triamcinolone—psoriatic arthritis	6.56e-05	0.000551	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisolone—psoriatic arthritis	6.54e-05	0.00055	CcSEcCtD
Fentanyl—Paraesthesia—Methylprednisolone—psoriatic arthritis	6.54e-05	0.00055	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—psoriatic arthritis	6.54e-05	0.00055	CcSEcCtD
Fentanyl—Anaemia—Prednisone—psoriatic arthritis	6.54e-05	0.000549	CcSEcCtD
Fentanyl—Shock—Betamethasone—psoriatic arthritis	6.52e-05	0.000548	CcSEcCtD
Fentanyl—Shock—Dexamethasone—psoriatic arthritis	6.52e-05	0.000548	CcSEcCtD
Fentanyl—Dyspnoea—Triamcinolone—psoriatic arthritis	6.51e-05	0.000547	CcSEcCtD
Fentanyl—Nervous system disorder—Betamethasone—psoriatic arthritis	6.5e-05	0.000546	CcSEcCtD
Fentanyl—Nervous system disorder—Dexamethasone—psoriatic arthritis	6.5e-05	0.000546	CcSEcCtD
Fentanyl—Agitation—Prednisone—psoriatic arthritis	6.5e-05	0.000546	CcSEcCtD
Fentanyl—Thrombocytopenia—Dexamethasone—psoriatic arthritis	6.49e-05	0.000546	CcSEcCtD
Fentanyl—Thrombocytopenia—Betamethasone—psoriatic arthritis	6.49e-05	0.000546	CcSEcCtD
Fentanyl—Tachycardia—Betamethasone—psoriatic arthritis	6.47e-05	0.000544	CcSEcCtD
Fentanyl—Tachycardia—Dexamethasone—psoriatic arthritis	6.47e-05	0.000544	CcSEcCtD
Fentanyl—Dyspepsia—Triamcinolone—psoriatic arthritis	6.43e-05	0.000541	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—psoriatic arthritis	6.42e-05	0.00054	CcSEcCtD
Fentanyl—Dyspepsia—Methylprednisolone—psoriatic arthritis	6.41e-05	0.000539	CcSEcCtD
Fentanyl—Hyperhidrosis—Dexamethasone—psoriatic arthritis	6.41e-05	0.000539	CcSEcCtD
Fentanyl—Hyperhidrosis—Betamethasone—psoriatic arthritis	6.41e-05	0.000539	CcSEcCtD
Fentanyl—Malaise—Prednisone—psoriatic arthritis	6.38e-05	0.000536	CcSEcCtD
Fentanyl—Vertigo—Prednisone—psoriatic arthritis	6.35e-05	0.000534	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—psoriatic arthritis	6.34e-05	0.000533	CcSEcCtD
Fentanyl—Syncope—Prednisone—psoriatic arthritis	6.34e-05	0.000533	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—psoriatic arthritis	6.33e-05	0.000532	CcSEcCtD
Fentanyl—Anorexia—Betamethasone—psoriatic arthritis	6.32e-05	0.000531	CcSEcCtD
Fentanyl—Anorexia—Dexamethasone—psoriatic arthritis	6.32e-05	0.000531	CcSEcCtD
Fentanyl—Urticaria—Prednisolone—psoriatic arthritis	6.31e-05	0.00053	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—psoriatic arthritis	6.3e-05	0.00053	CcSEcCtD
Fentanyl—Fatigue—Triamcinolone—psoriatic arthritis	6.3e-05	0.000529	CcSEcCtD
Fentanyl—Fatigue—Methylprednisolone—psoriatic arthritis	6.28e-05	0.000528	CcSEcCtD
Fentanyl—Pain—Triamcinolone—psoriatic arthritis	6.25e-05	0.000525	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisone—psoriatic arthritis	6.22e-05	0.000523	CcSEcCtD
Fentanyl—Hypotension—Betamethasone—psoriatic arthritis	6.19e-05	0.000521	CcSEcCtD
Fentanyl—Hypotension—Dexamethasone—psoriatic arthritis	6.19e-05	0.000521	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—psoriatic arthritis	6.16e-05	0.000518	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—psoriatic arthritis	6.13e-05	0.000516	CcSEcCtD
Fentanyl—Convulsion—Prednisone—psoriatic arthritis	6.13e-05	0.000515	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—psoriatic arthritis	6.12e-05	0.000514	CcSEcCtD
Fentanyl—Hypertension—Prednisone—psoriatic arthritis	6.11e-05	0.000513	CcSEcCtD
Fentanyl—Chills—Methotrexate—psoriatic arthritis	6.09e-05	0.000512	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	6.04e-05	0.000508	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	6.04e-05	0.000508	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—psoriatic arthritis	6.02e-05	0.000506	CcSEcCtD
Fentanyl—Myalgia—Prednisone—psoriatic arthritis	6.02e-05	0.000506	CcSEcCtD
Fentanyl—Feeling abnormal—Triamcinolone—psoriatic arthritis	6.02e-05	0.000506	CcSEcCtD
Fentanyl—Feeling abnormal—Methylprednisolone—psoriatic arthritis	6.01e-05	0.000505	CcSEcCtD
Fentanyl—Anxiety—Prednisone—psoriatic arthritis	6e-05	0.000504	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—psoriatic arthritis	6e-05	0.000504	CcSEcCtD
Fentanyl—Insomnia—Betamethasone—psoriatic arthritis	5.99e-05	0.000504	CcSEcCtD
Fentanyl—Insomnia—Dexamethasone—psoriatic arthritis	5.99e-05	0.000504	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	5.98e-05	0.000503	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	5.96e-05	0.000501	CcSEcCtD
Fentanyl—Paraesthesia—Betamethasone—psoriatic arthritis	5.95e-05	0.0005	CcSEcCtD
Fentanyl—Paraesthesia—Dexamethasone—psoriatic arthritis	5.95e-05	0.0005	CcSEcCtD
Fentanyl—Discomfort—Prednisone—psoriatic arthritis	5.95e-05	0.0005	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—psoriatic arthritis	5.95e-05	0.0005	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—psoriatic arthritis	5.91e-05	0.000497	CcSEcCtD
Fentanyl—Erythema—Methotrexate—psoriatic arthritis	5.91e-05	0.000497	CcSEcCtD
Fentanyl—Hypersensitivity—Prednisolone—psoriatic arthritis	5.85e-05	0.000492	CcSEcCtD
Fentanyl—Dyspepsia—Betamethasone—psoriatic arthritis	5.83e-05	0.00049	CcSEcCtD
Fentanyl—Dyspepsia—Dexamethasone—psoriatic arthritis	5.83e-05	0.00049	CcSEcCtD
Fentanyl—Urticaria—Triamcinolone—psoriatic arthritis	5.8e-05	0.000488	CcSEcCtD
Fentanyl—Urticaria—Methylprednisolone—psoriatic arthritis	5.79e-05	0.000487	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—psoriatic arthritis	5.79e-05	0.000487	CcSEcCtD
Fentanyl—Body temperature increased—Triamcinolone—psoriatic arthritis	5.77e-05	0.000485	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—psoriatic arthritis	5.77e-05	0.000485	CcSEcCtD
Fentanyl—Oedema—Prednisone—psoriatic arthritis	5.77e-05	0.000485	CcSEcCtD
Fentanyl—Abdominal pain—Methylprednisolone—psoriatic arthritis	5.76e-05	0.000484	CcSEcCtD
Fentanyl—Decreased appetite—Dexamethasone—psoriatic arthritis	5.76e-05	0.000484	CcSEcCtD
Fentanyl—Decreased appetite—Betamethasone—psoriatic arthritis	5.76e-05	0.000484	CcSEcCtD
Fentanyl—Infection—Prednisone—psoriatic arthritis	5.73e-05	0.000482	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	5.72e-05	0.000481	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	5.72e-05	0.000481	CcSEcCtD
Fentanyl—Back pain—Methotrexate—psoriatic arthritis	5.72e-05	0.000481	CcSEcCtD
Fentanyl—Fatigue—Dexamethasone—psoriatic arthritis	5.71e-05	0.00048	CcSEcCtD
Fentanyl—Fatigue—Betamethasone—psoriatic arthritis	5.71e-05	0.00048	CcSEcCtD
Fentanyl—Shock—Prednisone—psoriatic arthritis	5.68e-05	0.000477	CcSEcCtD
Fentanyl—Pain—Betamethasone—psoriatic arthritis	5.67e-05	0.000476	CcSEcCtD
Fentanyl—Pain—Dexamethasone—psoriatic arthritis	5.67e-05	0.000476	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—psoriatic arthritis	5.66e-05	0.000476	CcSEcCtD
Fentanyl—Tachycardia—Prednisone—psoriatic arthritis	5.63e-05	0.000474	CcSEcCtD
Fentanyl—Skin disorder—Prednisone—psoriatic arthritis	5.61e-05	0.000471	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisone—psoriatic arthritis	5.58e-05	0.000469	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—psoriatic arthritis	5.57e-05	0.000468	CcSEcCtD
Fentanyl—Anorexia—Prednisone—psoriatic arthritis	5.5e-05	0.000462	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—psoriatic arthritis	5.48e-05	0.000461	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—psoriatic arthritis	5.46e-05	0.000459	CcSEcCtD
Fentanyl—Feeling abnormal—Betamethasone—psoriatic arthritis	5.46e-05	0.000459	CcSEcCtD
Fentanyl—Feeling abnormal—Dexamethasone—psoriatic arthritis	5.46e-05	0.000459	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	5.42e-05	0.000456	CcSEcCtD
Fentanyl—Gastrointestinal pain—Betamethasone—psoriatic arthritis	5.42e-05	0.000456	CcSEcCtD
Fentanyl—Hypersensitivity—Triamcinolone—psoriatic arthritis	5.38e-05	0.000452	CcSEcCtD
Fentanyl—Hypersensitivity—Methylprednisolone—psoriatic arthritis	5.37e-05	0.000451	CcSEcCtD
Fentanyl—Malaise—Methotrexate—psoriatic arthritis	5.33e-05	0.000448	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—psoriatic arthritis	5.31e-05	0.000446	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—psoriatic arthritis	5.29e-05	0.000445	CcSEcCtD
Fentanyl—Urticaria—Dexamethasone—psoriatic arthritis	5.26e-05	0.000443	CcSEcCtD
Fentanyl—Urticaria—Betamethasone—psoriatic arthritis	5.26e-05	0.000443	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	5.26e-05	0.000442	CcSEcCtD
Fentanyl—Dizziness—Prednisolone—psoriatic arthritis	5.25e-05	0.000442	CcSEcCtD
Fentanyl—Asthenia—Triamcinolone—psoriatic arthritis	5.24e-05	0.000441	CcSEcCtD
Fentanyl—Abdominal pain—Dexamethasone—psoriatic arthritis	5.24e-05	0.00044	CcSEcCtD
Fentanyl—Body temperature increased—Betamethasone—psoriatic arthritis	5.24e-05	0.00044	CcSEcCtD
Fentanyl—Body temperature increased—Dexamethasone—psoriatic arthritis	5.24e-05	0.00044	CcSEcCtD
Fentanyl—Abdominal pain—Betamethasone—psoriatic arthritis	5.24e-05	0.00044	CcSEcCtD
Fentanyl—Asthenia—Methylprednisolone—psoriatic arthritis	5.23e-05	0.00044	CcSEcCtD
Fentanyl—Insomnia—Prednisone—psoriatic arthritis	5.22e-05	0.000439	CcSEcCtD
Fentanyl—Paraesthesia—Prednisone—psoriatic arthritis	5.18e-05	0.000436	CcSEcCtD
Fentanyl—Pruritus—Triamcinolone—psoriatic arthritis	5.17e-05	0.000434	CcSEcCtD
Fentanyl—Cough—Methotrexate—psoriatic arthritis	5.16e-05	0.000434	CcSEcCtD
Fentanyl—Pruritus—Methylprednisolone—psoriatic arthritis	5.16e-05	0.000433	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—psoriatic arthritis	5.12e-05	0.00043	CcSEcCtD
Fentanyl—Dyspepsia—Prednisone—psoriatic arthritis	5.08e-05	0.000427	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—psoriatic arthritis	5.03e-05	0.000423	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—psoriatic arthritis	5.03e-05	0.000423	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—psoriatic arthritis	5.03e-05	0.000423	CcSEcCtD
Fentanyl—Decreased appetite—Prednisone—psoriatic arthritis	5.02e-05	0.000422	CcSEcCtD
Fentanyl—Rash—Prednisolone—psoriatic arthritis	5.01e-05	0.000421	CcSEcCtD
Fentanyl—Dermatitis—Prednisolone—psoriatic arthritis	5e-05	0.000421	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	5e-05	0.00042	CcSEcCtD
Fentanyl—Diarrhoea—Methylprednisolone—psoriatic arthritis	4.99e-05	0.000419	CcSEcCtD
Fentanyl—Fatigue—Prednisone—psoriatic arthritis	4.98e-05	0.000418	CcSEcCtD
Fentanyl—Headache—Prednisolone—psoriatic arthritis	4.98e-05	0.000418	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—psoriatic arthritis	4.97e-05	0.000418	CcSEcCtD
Fentanyl—Constipation—Prednisone—psoriatic arthritis	4.94e-05	0.000415	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—psoriatic arthritis	4.86e-05	0.000409	CcSEcCtD
Fentanyl—Dizziness—Triamcinolone—psoriatic arthritis	4.83e-05	0.000406	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—psoriatic arthritis	4.82e-05	0.000405	CcSEcCtD
Fentanyl—Dizziness—Methylprednisolone—psoriatic arthritis	4.82e-05	0.000405	CcSEcCtD
Fentanyl—Infection—Methotrexate—psoriatic arthritis	4.79e-05	0.000403	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisone—psoriatic arthritis	4.76e-05	0.0004	CcSEcCtD
Fentanyl—Asthenia—Betamethasone—psoriatic arthritis	4.75e-05	0.0004	CcSEcCtD
Fentanyl—Asthenia—Dexamethasone—psoriatic arthritis	4.75e-05	0.0004	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—psoriatic arthritis	4.73e-05	0.000398	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—psoriatic arthritis	4.72e-05	0.000397	CcSEcCtD
Fentanyl—Gastrointestinal pain—Prednisone—psoriatic arthritis	4.72e-05	0.000397	CcSEcCtD
Fentanyl—Nausea—Prednisolone—psoriatic arthritis	4.72e-05	0.000397	CcSEcCtD
Fentanyl—Pruritus—Betamethasone—psoriatic arthritis	4.69e-05	0.000394	CcSEcCtD
Fentanyl—Pruritus—Dexamethasone—psoriatic arthritis	4.69e-05	0.000394	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—psoriatic arthritis	4.68e-05	0.000394	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—psoriatic arthritis	4.66e-05	0.000392	CcSEcCtD
Fentanyl—Vomiting—Triamcinolone—psoriatic arthritis	4.64e-05	0.00039	CcSEcCtD
Fentanyl—Vomiting—Methylprednisolone—psoriatic arthritis	4.63e-05	0.00039	CcSEcCtD
Fentanyl—Rash—Triamcinolone—psoriatic arthritis	4.61e-05	0.000387	CcSEcCtD
Fentanyl—Dermatitis—Triamcinolone—psoriatic arthritis	4.6e-05	0.000387	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—psoriatic arthritis	4.6e-05	0.000387	CcSEcCtD
Fentanyl—Rash—Methylprednisolone—psoriatic arthritis	4.59e-05	0.000386	CcSEcCtD
Fentanyl—Dermatitis—Methylprednisolone—psoriatic arthritis	4.59e-05	0.000386	CcSEcCtD
Fentanyl—Urticaria—Prednisone—psoriatic arthritis	4.58e-05	0.000385	CcSEcCtD
Fentanyl—Headache—Triamcinolone—psoriatic arthritis	4.58e-05	0.000385	CcSEcCtD
Fentanyl—Headache—Methylprednisolone—psoriatic arthritis	4.57e-05	0.000384	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—psoriatic arthritis	4.56e-05	0.000384	CcSEcCtD
Fentanyl—Abdominal pain—Prednisone—psoriatic arthritis	4.56e-05	0.000384	CcSEcCtD
Fentanyl—Diarrhoea—Dexamethasone—psoriatic arthritis	4.53e-05	0.000381	CcSEcCtD
Fentanyl—Diarrhoea—Betamethasone—psoriatic arthritis	4.53e-05	0.000381	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—psoriatic arthritis	4.51e-05	0.000379	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	4.39e-05	0.000369	CcSEcCtD
Fentanyl—Dizziness—Dexamethasone—psoriatic arthritis	4.38e-05	0.000368	CcSEcCtD
Fentanyl—Dizziness—Betamethasone—psoriatic arthritis	4.38e-05	0.000368	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—psoriatic arthritis	4.36e-05	0.000367	CcSEcCtD
Fentanyl—Nausea—Triamcinolone—psoriatic arthritis	4.34e-05	0.000365	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—psoriatic arthritis	4.33e-05	0.000364	CcSEcCtD
Fentanyl—Nausea—Methylprednisolone—psoriatic arthritis	4.33e-05	0.000364	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—psoriatic arthritis	4.3e-05	0.000362	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—psoriatic arthritis	4.29e-05	0.00036	CcSEcCtD
Fentanyl—Hypersensitivity—Prednisone—psoriatic arthritis	4.25e-05	0.000357	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—psoriatic arthritis	4.25e-05	0.000357	CcSEcCtD
Fentanyl—Vomiting—Dexamethasone—psoriatic arthritis	4.21e-05	0.000354	CcSEcCtD
Fentanyl—Vomiting—Betamethasone—psoriatic arthritis	4.21e-05	0.000354	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—psoriatic arthritis	4.19e-05	0.000352	CcSEcCtD
Fentanyl—Rash—Betamethasone—psoriatic arthritis	4.18e-05	0.000351	CcSEcCtD
Fentanyl—Rash—Dexamethasone—psoriatic arthritis	4.18e-05	0.000351	CcSEcCtD
Fentanyl—Dermatitis—Betamethasone—psoriatic arthritis	4.17e-05	0.000351	CcSEcCtD
Fentanyl—Dermatitis—Dexamethasone—psoriatic arthritis	4.17e-05	0.000351	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	4.16e-05	0.00035	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—psoriatic arthritis	4.16e-05	0.00035	CcSEcCtD
Fentanyl—Headache—Betamethasone—psoriatic arthritis	4.15e-05	0.000349	CcSEcCtD
Fentanyl—Headache—Dexamethasone—psoriatic arthritis	4.15e-05	0.000349	CcSEcCtD
Fentanyl—Asthenia—Prednisone—psoriatic arthritis	4.14e-05	0.000348	CcSEcCtD
Fentanyl—Pain—Methotrexate—psoriatic arthritis	4.12e-05	0.000347	CcSEcCtD
Fentanyl—Pruritus—Prednisone—psoriatic arthritis	4.08e-05	0.000343	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—psoriatic arthritis	3.97e-05	0.000334	CcSEcCtD
Fentanyl—Diarrhoea—Prednisone—psoriatic arthritis	3.95e-05	0.000332	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—psoriatic arthritis	3.94e-05	0.000332	CcSEcCtD
Fentanyl—Nausea—Dexamethasone—psoriatic arthritis	3.94e-05	0.000331	CcSEcCtD
Fentanyl—Nausea—Betamethasone—psoriatic arthritis	3.94e-05	0.000331	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—psoriatic arthritis	3.83e-05	0.000322	CcSEcCtD
Fentanyl—Dizziness—Prednisone—psoriatic arthritis	3.82e-05	0.000321	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—psoriatic arthritis	3.81e-05	0.000321	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—psoriatic arthritis	3.81e-05	0.000321	CcSEcCtD
Fentanyl—Vomiting—Prednisone—psoriatic arthritis	3.67e-05	0.000308	CcSEcCtD
Fentanyl—Rash—Prednisone—psoriatic arthritis	3.64e-05	0.000306	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—psoriatic arthritis	3.64e-05	0.000306	CcSEcCtD
Fentanyl—Headache—Prednisone—psoriatic arthritis	3.62e-05	0.000304	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—psoriatic arthritis	3.55e-05	0.000299	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—psoriatic arthritis	3.46e-05	0.000291	CcSEcCtD
Fentanyl—Nausea—Prednisone—psoriatic arthritis	3.43e-05	0.000288	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—psoriatic arthritis	3.41e-05	0.000287	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—psoriatic arthritis	3.3e-05	0.000277	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—psoriatic arthritis	3.19e-05	0.000268	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—psoriatic arthritis	3.07e-05	0.000258	CcSEcCtD
Fentanyl—Rash—Methotrexate—psoriatic arthritis	3.04e-05	0.000256	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—psoriatic arthritis	3.04e-05	0.000255	CcSEcCtD
Fentanyl—Headache—Methotrexate—psoriatic arthritis	3.02e-05	0.000254	CcSEcCtD
Fentanyl—Nausea—Methotrexate—psoriatic arthritis	2.86e-05	0.000241	CcSEcCtD
